Joshua Disbrow | executive |
Mark Oki | executive |
Nazibur Rahman | analyst |
Greetings. Welcome to the Aytu Biopharma fiscal 2023 Q4 Earnings Conference Call. [Operator Instructions] Please note this conference is being recorded.
I will now turn the conference over to your host, Robert Blum, Investor Relations. Robert, you may begin.